[
  {
    "ts": null,
    "headline": "Large-cap biotech is a sector to watch for investors: Analysts",
    "summary": "Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere.",
    "url": "https://finnhub.io/api/news?id=0662f07a31d05278cb660cdf2621d1dc4a73cf29cd67af073f9e563f506cfd9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756644000,
      "headline": "Large-cap biotech is a sector to watch for investors: Analysts",
      "id": 136588775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere.",
      "url": "https://finnhub.io/api/news?id=0662f07a31d05278cb660cdf2621d1dc4a73cf29cd67af073f9e563f506cfd9c"
    }
  },
  {
    "ts": null,
    "headline": "3 No-Brainer Stocks to Buy Right Now",
    "summary": "Investing in these pharmaceutical stocks is an easy decision.",
    "url": "https://finnhub.io/api/news?id=d7d49c500aac03068049e36c930b89476a36ae0e2b32058fc9675b5ebc93e8b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756637100,
      "headline": "3 No-Brainer Stocks to Buy Right Now",
      "id": 136590760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investing in these pharmaceutical stocks is an easy decision.",
      "url": "https://finnhub.io/api/news?id=d7d49c500aac03068049e36c930b89476a36ae0e2b32058fc9675b5ebc93e8b9"
    }
  },
  {
    "ts": null,
    "headline": "8 'Safer' Dividend Buys In Barron's 23 Better Bets (BBB) Than T-Bills August Report",
    "summary": "Discover 23 top dividend stocks with yields over 4.2%âoffering solid income and growth, even as bond yields rise.",
    "url": "https://finnhub.io/api/news?id=78b826f2f4929c04d82d57c22204b78156dff72a52c6b812f318654c556f6845",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756639131,
      "headline": "8 'Safer' Dividend Buys In Barron's 23 Better Bets (BBB) Than T-Bills August Report",
      "id": 136588415,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212827183/image_2212827183.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover 23 top dividend stocks with yields over 4.2%âoffering solid income and growth, even as bond yields rise.",
      "url": "https://finnhub.io/api/news?id=78b826f2f4929c04d82d57c22204b78156dff72a52c6b812f318654c556f6845"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced on August 27 the US Food and Drug Administration’s (FDA) approval of the supplemental Biologics License Application (sBLA) for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA). The vaccine is to be […]",
    "url": "https://finnhub.io/api/news?id=b53deb6c33ba184870373d4368a1b7dca3f9418e70480353d293d222eb6d9083",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756613437,
      "headline": "Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine",
      "id": 136588776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced on August 27 the US Food and Drug Administration’s (FDA) approval of the supplemental Biologics License Application (sBLA) for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA). The vaccine is to be […]",
      "url": "https://finnhub.io/api/news?id=b53deb6c33ba184870373d4368a1b7dca3f9418e70480353d293d222eb6d9083"
    }
  }
]